| PRODUCT NAME | CAS Registry Number | ||||||||
| Tadalafil Spiro-urethane Impurity (EP Impurity F) (1 supplier) | 2186605-14-9 | ||||||||
| Tadalafil-[13C,d3] (3 suppliers) | 1261364-86-6 | ||||||||
| Tadalafil-13C-d3 (1 supplier) | |||||||||
Tadalafil-d3 (7 suppliers)
Synonyms: Tildenafil-d3, Cialis-d3, Tadalafil-methyl-d3, ICOS 351-d3, CTK8G3295, IC 351-d3, GF 196960-d3, UK 336017-d3, AG-B-51749, FT-0674789, (6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-(methyl-d3)pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione
InChIKey: WOXKDUGGOYFFRN-WFMNTJQSSA-N | 960226-55-5 | ||||||||
| Taddol II (1 supplier) | 137512-80-2 | ||||||||
| tadecyl)oxy]- (0 suppliers) | 338979-91-2 | ||||||||
| Tadehaginoside (2 suppliers) | 2020004-61-7 | ||||||||
| Tadehaginoside E (2 suppliers) | 1912408-00-4 | ||||||||
| TADEKINIGUM ALFA (2 suppliers) | 220712-29-8 | ||||||||
| TADJAKONINE (2 suppliers) | 11087-94-8 | ||||||||
| Tadnersen (3 suppliers) | 2170507-65-8 | ||||||||
| tadocizumab (4 suppliers) | 339086-80-5 | ||||||||
| Tadpole edema virusTadshiferin (1 supplier) | 62023-94-3 | ||||||||
| Tadshikorin (1 supplier) | 62023-95-4 | ||||||||
TAE-1 (8 suppliers)
IUPAC Name: 2-[4-[[4,6-bis[4-[2-(trimethylazaniumyl)ethoxycarbonyl]phenoxy]-1,3,5-triazin-2-yl]oxy]benzoyl]oxyethyl-trimethylazanium;triiodide | CAS Registry Number: 1414469-59-2Synonyms: AOB4466, SYN5029, C39H51I3N6O3
InChIKey: SGOMELGTKOLYEZ-UHFFFAOYSA-K | 1414469-59-2 | ||||||||
| TAE648 (1 supplier) | 2769753-10-6 | ||||||||
| TAEM (5 suppliers) | 89604-93-2 | ||||||||
| TAENIAESTATIN (3 suppliers) | 105542-46-9 | ||||||||
| Taeniolite(LiK[MgF(Si2O5)]2) (1 supplier) | 12020-86-9 | ||||||||
| TAENITE (FE0.35-0.73NI0.27-0.65) (2 suppliers) | 12178-47-1 | ||||||||
| TAF1 ligand 1 (1 supplier) | 1926986-25-5 | ||||||||
| TAF12 Protein, Human, Recombinant (His & SUMO) (1 supplier) | |||||||||
| TAF5L Protein, Human, Recombinant (GST) (1 supplier) | |||||||||
| TAF7L Protein, Human, Recombinant (His & Myc) (1 supplier) | |||||||||
| TAFA1/FAM19A1 Protein, Mouse, Recombinant (His & Myc) (1 supplier) | |||||||||
| TAFA2/FAM19A2 Protein, Human, Recombinant (hFc) (1 supplier) | |||||||||
| TAFA4 Protein, Human, Recombinant (His) (1 supplier) | |||||||||
Tafamidis (12 suppliers)
IUPAC Name: 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid | CAS Registry Number: 594839-88-0Synonyms: TAFAMIDIS, UNII-8FG9H9D31J, FX-1006, 2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid, 3MI, Tafamidis (USAN/INN), Tafamidis [USAN:INN], SureCN442508, 8FG9H9D31J, CHEMBL2103837, Fx 1006, FX 005, KB-77492, D09673, 2-(3,5-Dichlorophenyl)-6-benzoxazolecarboxylic Acid, 2-(3,5-dichlorophenyl)benzoxazole-6-carboxylic acid, 6-Benzoxazolecarboxylic acid, 2-(3,5-dichlorophenyl)-, 137464-18-7
InChIKey: TXEIIPDJKFWEEC-UHFFFAOYSA-N | 594839-88-0 | ||||||||
| Tafamidis Impurity 5 (1 supplier) | 1183404-30-9 | ||||||||
tafamidis meglumine (7 suppliers)
IUPAC Name: 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol | CAS Registry Number: 951395-08-7Synonyms: Tafamidis meglumine, Vyndaqel, Fx-1006A, Fx1006A, Fx 1006A, UNII-ZU7CF08A1A, CHEBI:79345, Vyndaqel (TN), ZU7CF08A1A, CHEMBL2105675, SCHEMBL14783506, Tafamidis meglumine (JAN/USAN), Tafamidis meglumine [USAN:INN], PF-06291826, D09674, D-Glucitol, 1-deoxy-1-(methylamino)-, 2-(3,5-dichlorophenyl)-6-benzoxazolecarboxylate, 1-deoxy-1-(methylazaniumyl)-D-glucitol 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylate, 2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid--1-deoxy-1-(methylamino)-D-glucitol (1/1)
InChIKey: DQJDBUPLRMRBAB-WZTVWXICSA-N | 951395-08-7 | ||||||||
| Tafamidis-d3 (1 supplier) | |||||||||
| Tafasitamab (4 suppliers) | 1422527-84-1 | ||||||||
Tafenoquine (13 suppliers)
IUPAC Name: 4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine | CAS Registry Number: 106635-80-7Synonyms: Tafenoquine [INN:BAN], UNII-262P8GS9L9, C24H28F3N3O3, CHEBI:172505, AIDS006901, 106635-81-8 (maleate), AIDS-006901, CID115358, WR 238605, WR-238605, WR238605, LS-172012, 1,4-Pentanediamine, N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-, N(4)-(2,6-Dimethoxy-4-methyl-5-((3-trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine, N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]diamine, (4-Amino-1-methylbutyl){2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy](8-quinolyl)}amine, (R)-N3-(2,6-Dimethoxy-4-methyl-5-(3-trifluoromethyl)phenoxy)quinolin-8-yl)pentane-1,4-diamine, (RS)-N(sup 3)-(2,6-Dimethoxy-4-methyl-5-(3-trifluoro-methylphenoxy)quinolin-8-yl)pentane-1,4-diamine, 1,4-Pentanediamine, N4-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]-8-quinolinyl]-, Butanedioic acid, compd. with N4-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
InChIKey: LBHLFPGPEGDCJG-UHFFFAOYSA-N | 106635-80-7 | ||||||||
Tafenoquine Succinate (12 suppliers)
IUPAC Name: butanedioic acid; 4-N-[2,6-dimethoxy-4-methyl-5-[3-(trifluoromethyl)phenoxy]quinolin-8-yl]pentane-1,4-diamine | CAS Registry Number: 106635-81-8Synonyms: Etaquine, tafenoquine maleate, WR238605 succinate, Tafenoquine succinate, 106635-80-7 (Parent), CID163761, C24H28F3N3O3.C4H6O4, WR 238605, LS-45733, SB-252263, WR-238605, Butanedioic acid, compd. with N(sup 4)-(2,6-dimethoxy-4-methyl-5-(3-(trifluoromethyl)phenoxy)-8-quinolinyl)-1,4-pentanediamine (1:1)
InChIKey: CQBKFGJRAOXYIP-UHFFFAOYSA-N | 106635-81-8 | ||||||||
Tafetinib (4 suppliers)
IUPAC Name: (7Z)-N-[2-(diethylamino)ethyl]-7-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-methyl-1,4,5,6-tetrahydroindole-3-carboxamide | CAS Registry Number: 1032265-57-8Synonyms: tafetinib, SIM-010603, UNII-H4X2M2NN5N, SIM 010603, H4X2M2NN5N, CHEMBL2180602, GTPL9921, SCHEMBL12056459, SCHEMBL16457807, BDBM50399535, Q27895956, (7Z)-N-(2-(Diethylamino)ethyl)-7-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-2-methyl-1H-indole-3-carboxamide, (7Z)-N-(2-Diethylaminoethyl)-7-(5-fluoro-2-oxo-indolin-3-ylidene)-2-methyl-1,4,5,6-tetrahydroindole-3-carboxamide, (7Z)-N-[2-(diethylamino)ethyl]-7-(5-fluoro-2-oxo-1H-indol-3-ylidene)-2-methyl-1,4,5,6-tetrahydroindole-3-carboxamide, (z)-N-(2-(diethylamino)ethyl)-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3h-indol-3-ylidene)-4,5,6,7-tetrahydro-1h-indole-3-carboxamide, (Z)-N-[2-(diethylamino)ethyl]-2-methyl-7-(1,2-dihydro-5-fluoro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-1H-indol-3-carboxamide, 1H-Indole-3-carboxamide, N-(2-(diethylamino)ethyl)-7-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4,5,6,7-tetrahydro-2-methyl-, (7Z)-
InChIKey: KGSRYTUWXUESJK-FXBPSFAMSA-N | 1032265-57-8 | ||||||||
Tafluposide (7 suppliers)
IUPAC Name: [(2R,4aR,6R,7R,8S,8aR)-6-[[(5S,5aR,8aR,9R)-9-(3,5-dimethoxy-4-phosphonooxyphenyl)-8-oxo-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-5-yl]oxy]-2-methyl-7-[2-(2,3,4,5,6-pentafluorophenoxy)acetyl]oxy-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-8-yl] 2-(2,3,4,5,6-pentafluorophenoxy)acetate | CAS Registry Number: 179067-42-6Synonyms: Tafluposide [INN], UNII-QN043X3ZDW, 4-((5R,5aR,8aR,9S)-9-((4,6-O-((1R)-Ethylidene)-2,3-bisO-((pentafluorophenoxy)acetyl)-beta-D-glucopyranosyl)oxy)-6-oxo-5,5a,6,8,8a,9-hexahydrofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-2,6-dimethoxyphenyle dihydrogen phosphate
InChIKey: RTJVUHUGTUDWRK-CSLCKUBZSA-N | 179067-42-6 | ||||||||
Tafluprost (17 suppliers)
IUPAC Name: propan-2-yl (Z)-7-[(1R,2R,3R,5S)-2-[(E)-3,3-difluoro-4-(phenoxy)but-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate | CAS Registry Number: 209860-87-7Synonyms: Taflotan, Tapros, Tafluprost [INN], AFP-168, DE-085, CID9868491, Isopropyl (5Z)-7-{(1R,2R,3R,5S)-2-((1E)-3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl}hept-5-enoate
InChIKey: WSNODXPBBALQOF-VEJSHDCNSA-N | 209860-87-7 | ||||||||
Tafluprost acid (12 suppliers)
IUPAC Name: 7-[2-(3,3-difluoro-4-phenoxybut-1-enyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid | CAS Registry Number: 209860-88-8Synonyms: Tafluprost (free acid), CTK8F0766
InChIKey: KIQXRQVVYTYYAZ-UHFFFAOYSA-N | 209860-88-8 | ||||||||
| TAFLUPROST ENON, 97+% (0 suppliers) | 51639-91-6 | ||||||||
| Tafluprost Impurity 19 (2 suppliers) | 2587078-46-2 | ||||||||
Tafluprost Impurity 22 (1 supplier)
IUPAC Name: propan-2-yl (Z)-7-[(1S,2S,3S,5R)-2-[(E)-3,3-difluoro-4-phenoxybut-1-enyl]-3,5-dihydroxycyclopentyl]hept-5-enoate | CAS Registry Number: 2587078-47-3Synonyms: (Z)-Isopropyl 7-((1S,2S,3S,5R)-2-((E)-3,3-difluoro-4-phenoxybut-1-en-1-yl)-3,5-dihydroxycyclopentyl)hept-5-enoate, (-)-Tafluprost, Tafluprost, (-)-, FYS86R4ZFS, 1-Methylethyl (5Z)-7-[(1S,2S,3S,5R)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoate, 5-Heptenoic acid, 7-[(1S,2S,3S,5R)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, 1-methylethyl ester, (5Z)-
InChIKey: WSNODXPBBALQOF-XHDZIRLISA-N | 2587078-47-3 | ||||||||
| Tafluprost Impurity 4 (2 suppliers) | 1563176-58-8 | ||||||||
| Tafluprost Impurity 8 (1 supplier) | 2278245-92-2 | ||||||||
| Tafluprost-d7 (0 suppliers) | 2714484-60-1 | ||||||||
| Tafolecimab (2 suppliers) | 2225109-03-3 | ||||||||
| Tafuramycin A (1 supplier) | 494868-78-9 | ||||||||
| TAG-72 Protein, Canine, Recombinant (His) (1 supplier) | |||||||||
| TAG-NHS-ESTER; TRIS(2,2'-BIPYRIDYL) RUTHENIUM NHS ESTER (3 suppliers) | 161698-59-5 | ||||||||
| TAG1/Contactin 2 Protein, Human, Recombinant (His) (1 supplier) | |||||||||
| TAG1/Contactin 2 Protein, Mouse, Recombinant (His) (1 supplier) |